ONO-5129

· Ono Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ONO-5129, covering 2012-06-13 to 2012-10-11. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Study to Evaluate the Effects of Oral ONO-5129 in Type 2 Diabetes Mellitus [Phase 2]